Midas Pharmasec (Delisted) financials and balance sheet

BSE: 530257

Last traded ₹28.55 on 28 Jun 2011

Delisted on 3 Aug 2011.

4 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Midas Pharmasec annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
Peak revenue ₹0.62 Cr, year to Mar 2011A loss in 2 of the 4 years shown

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2011

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue0.6
  2. Finance costs0.0
  3. Profit before tax0.5
  4. Tax−0.1
  5. Net profit0.4

Profit and loss

Standalone, ₹ crore, years to March.Midas Pharmasec quarterly results

₹ croreMar 2008Mar 2009Mar 2010Mar 2011
Revenue from operations−0.04−0.070.310.62
Depreciation and amortisation0.000.00––
Other income–0.01––
Finance costs–––0.02
Profit before tax−0.27−1.140.210.49
Tax–0.000.030.09
Net profit−0.27−1.140.180.40
Net margin768.6%1,545.9%56.1%64.4%
Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the years to Mar 2008 and Mar 2009: the statement does not state its finance costs, which operating profit is worked out from, so operating profit is not given. Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the year to Mar 2010: the statement does not state its finance costs or depreciation, which operating profit is worked out from, so operating profit is not given. Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the year to Mar 2011: the statement does not state its depreciation, which operating profit is worked out from, so operating profit is not given.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2010Mar 2011
Earnings per share₹0.18–
Diluted earnings per share₹0.18–
Market cap at the year end (₹ crore)15.727.7

Ratios

Standalone, years to March.

RatioMar 2011
Revenue growth97.8%
Net profit growth127.3%

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2011.

Measure5 years3 years
Net margin, average608.7%555.5%

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2010Mar 2011
Effective tax ratePublished threshold 17.16 per cent15.3818.53
A threshold marked as ours has no published figure; it is the line we read the check against.